Selenious Acid.

Selenium is incorporated as selenocysteine into the active site of glutathione peroxidase, so selenium supply sets how much of that enzyme can be built. This is the textbook cofactor relationship for the element.

Selenite reacts with glutathione to form selenodiglutathione and then hydrogen selenide, which is how inorganic selenium enters the selenoprotein pathway. The reaction consumes glutathione, so a heavy selenite load draws on that pool.

NAC supplies cysteine for glutathione synthesis, and it is that thiol pool which reduces selenite on its way to selenide. Adequate thiol supply keeps the conversion step running.

Free cysteine thiols reduce selenite directly, the same chemistry glutathione performs. Cysteine is also the amino acid backbone into which selenium is placed to make selenocysteine.

High-dose ascorbate reduces selenite to red elemental selenium in the gut lumen, a form that is barely absorbed, so the two taken at the same moment lower selenium uptake. Separating the doses avoids the reaction.

Vitamin C in the same dose converts selenite to elemental selenium, which passes through largely unabsorbed. This is the classic reason inorganic selenium and high-dose vitamin C are spaced apart.

Vitamin E stops the propagation of lipid radical chains inside the membrane while the selenium-dependent glutathione peroxidases remove the hydroperoxides that are already formed. The sparing relationship between the two is textbook nutrition.

Alpha-tocopherol quenches lipid radicals in the membrane and selenoenzymes clear the resulting peroxides, so each spares the other. Their requirements move together for this reason.

The deiodinases that convert thyroxine to the active triiodothyronine are selenoproteins, so normal thyroid hormone conversion needs both iodine and selenium. A formula supplying one without the other leaves the sequence short at one end.

Selenious acid is one selenium source among several and all forms add to the same total elemental intake. Stacking sources without counting the combined amount pushes past the intended dose.

Selenomethionine is incorporated non-specifically into body proteins in place of methionine and builds a storage pool, whereas selenite feeds the selenoprotein pathway more directly. The two add to the same total selenium intake by different routes.

Methylselenocysteine is cleaved to methylselenol without passing through the selenide pool, so it enters selenium metabolism at a different point than selenite. Both still add to total selenium intake.

Selenate is reduced to selenite and then to selenide, so it converges on the same pathway as selenious acid one step upstream. The two are additive on total selenium.

Selenide not used for selenoprotein synthesis is methylated by SAM-dependent methyltransferases to methylselenol and onward to the excreted forms. Methyl group supply therefore sits on the disposal side of selenium handling.

Betaine regenerates methionine and so supports the SAM pool that methylates excess selenide toward excretion. The link is one step removed from selenium itself.

Copper-zinc superoxide dismutase converts superoxide to hydrogen peroxide, and the selenium-dependent glutathione peroxidases then reduce that peroxide to water. The two minerals sit at consecutive steps of the same defence sequence rather than duplicating each other. Very high zinc intake is separately known to interfere with copper status, which is the other half of that first enzyme.

Hydrogen selenide, the reduced intermediate of selenite metabolism, binds metal ions tightly and forms poorly soluble metal selenides, which is the same chemistry behind selenium's known interactions with heavy metals. Copper appears in the co-occurrence index for this compound and is flagged there as antagonistic. Copper is also required for the superoxide dismutase that works upstream of the selenium-dependent peroxidases, so the relationship runs both directions and is worth stating rather than simplifying.

The reaction of selenite with glutathione generates reactive intermediates, and redox-active free iron accelerates the formation of reactive oxygen species from peroxides. Taking a large inorganic selenium dose alongside a large unbound iron dose puts two redox-active species in the same lumen. This is chemistry rather than a measured clinical interaction, and it is one reason inorganic selenium is dosed in micrograms.

Thioredoxin reductase and glutathione reductase are both FAD-dependent flavoenzymes, and riboflavin is the precursor of FAD. Those two enzymes regenerate the reduced thiols that selenite consumes on its way to selenide and that glutathione peroxidase needs to keep working. Riboflavin status therefore sits underneath both the conversion of the selenium salt and the function of the selenoproteins it builds.

Dihydrolipoic acid is a dithiol capable of reducing selenite in the same way glutathione does, and it also regenerates glutathione and ascorbate from their oxidised forms. That places it on the reducing side of selenium activation. The interaction is chemically well described; its size at supplement doses in people is not established here.

Pyridoxal 5-phosphate drives the transsulfuration enzymes that make cysteine from methionine, and cysteine is the limiting precursor for the glutathione that reduces selenite. The same cofactor serves selenocysteine lyase, which frees selenium from selenocysteine for reuse. Both the entry and the recycling of selenium depend on it.

Selenium beyond what selenoprotein synthesis needs is methylated to methylselenol, then to dimethylselenide exhaled in breath and trimethylselenonium excreted in urine. Those methyl groups come from S-adenosylmethionine, regenerated with folate. Methyl donor supply therefore affects the clearance side of a selenium dose rather than its uptake.

Methionine synthase requires B12 to regenerate methionine from homocysteine and so to refill the S-adenosylmethionine pool. That pool supplies the methylation steps that dispose of surplus selenium. The connection is a shared dependency, not a direct reaction between the two compounds.

Selenomethionine follows the methionine pathway and is placed non-specifically into body protein, building a tissue reservoir. Selenite from selenious acid does not do that; it goes straight into the reduction route toward selenoprotein synthesis or methylated excretion. That difference is why inorganic and organic selenium behave differently on repeat dosing even at the same elemental dose.

Ubiquinol is a lipid-phase antioxidant while the selenium-dependent peroxidases act largely on peroxides in the aqueous and membrane phases, and thioredoxin reductase participates in regenerating other antioxidants. The two therefore occupy different compartments of the same network. Combination work exists in the wider selenium literature but none is cited for this compound here.

Selenite absorption is largely passive and is influenced by the chemistry of the surrounding lumen, and a carbonate antacid raises gastric and upper intestinal pH. Reduced species and precipitation behaviour shift with pH. The direction is plausible from chemistry; no measurement of the pairing is cited here, so it stays at the lowest confidence.

Isothiocyanates are conjugated to glutathione and then processed through the mercapturic acid pathway, drawing on the same thiol pool that selenite reduction consumes. Both also induce related cytoprotective enzyme responses. The overlap is real chemistry at high exposures and unquantified at ordinary supplement doses.

Molybdate and sulfate compete with selenate for shared anion transporters, but selenite from selenious acid is not carried by that system, so the competition that matters for selenate does not apply the same way here. The row exists to mark that difference rather than to claim an interaction. It is mechanistic and should be read that way.